BRAWN BIOTECH LTD.
BSE: 530207
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.98-54.2% | 4.31-11.8% | 4.89-15.6% | 5.80+156.6% | 2.26-41.2% | 3.85+16.6% | 3.30-18.8% | 4.06 |
| Other Income | 0.18+98.8% | 0.09-0.2% | 0.09+0.3% | 0.09-0.3% | 0.09+9020.0% | 0.00+0.0% | 0.00 | — |
| Total Income | 2.16-51.0% | 4.40-11.6% | 4.98-15.4% | 5.89+150.5% | 2.35-38.9% | 3.85+16.6% | 3.30-18.8% | 4.06 |
| EXPENSES | ||||||||
| Expenditure | 2.51-42.3% | 4.35-11.3% | 4.91-13.1% | 5.65+98.7% | 2.84-33.5% | 4.28+17.4% | 3.64-20.7% | 4.59 |
| Tax | -0.94 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| PROFIT | ||||||||
| PBT | -0.36-812.4% | 0.05-30.0% | 0.07-69.7% | 0.24+147.7% | -0.49-14.4% | -0.43-25.6% | -0.34+35.1% | -0.53 |
| Net Profit | 0.58+1066.6% | 0.05-30.0% | 0.07-69.7% | 0.24+147.7% | -0.49-14.4% | -0.43-25.6% | -0.34+35.1% | -0.53 |
| KEY METRICS | ||||||||
| OPM % | -25.54%-23.89pp | -1.65%-1.92pp | 0.27%-2.77pp | 3.04%+27.48pp | -24.44%-12.37pp | -12.07%-0.73pp | -11.34%+1.71pp | -13.05% |
| NPM % | 27.04%+25.90pp | 1.14%-0.29pp | 1.43%-2.58pp | 4.01%+25.04pp | -21.03%-9.80pp | -11.23%-0.80pp | -10.43%+2.62pp | -13.05% |
| EPS | 1.95+1047.1% | 0.17-32.0% | 0.25-71.9% | 0.89-46.1% | 1.65+214.6% | -1.44-50.0% | -0.96-433.3% | -0.18 |
Corporate Events
Board MeetingBRAWN
202629May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingBRAWN
202414Nov
Board Meeting
CONSIDERING AND APPROVING THE UNAUDITED FINANCIAL RESULTS
BSE Filing ↗ Board MeetingBRAWN
202414Aug
Board Meeting
Consider and approve Unaudited Financial Results
BSE Filing ↗ Board MeetingBRAWN
202429May
Board Meeting
Consider and approve the audited financial results
BSE Filing ↗